Duoning Wins the Annual Health Service Platform of the 2022 Changchun Award

SHANGHAI, Nov. 16, 2022——The annual list of the Changchun Awards was released at the 2022 Jiemian Health Forum. With its one-stop biotechnology solutions and comprehensive products and services, Shanghai Duoning Biotechnology Co., Ltd. ("Duoning ") won the Annual Health Service Platform Award.

The Changchun Award, hosted by Jiemian News, focuses on the upgrading and changes of life science industry. In a rigorous review of innovation, accessibility, and brand reputation, Duoning stood out from more than 200 companies and won the sole Annual Health Service Platform Award.

Adhering to the mission of "empower life sciences and promote human health and well-being", Duoning has been committed to providing one-stop bioprocessing solutions with high quality and accessibility for pharmaceutical companies, CROs/CDMOs and scientific research institutions. After nearly 20 years of development, Duoning has established a wide range of businesses in the fields of reagents and consumables, equipment, and laboratory products and services, and has expanded markets at home and abroad. As of September 21, 2022, Duoning has made significant breakthroughs in several key product areas:

● Among the domestic cell culture medium provides, the company with the greatest number of antibody and CGT projects whose cell culture medium is used to enter the BLA stage and commercialization stage

● The first and only company in China that completed the registrations for both self-developed single-use films and tubes with the DMF in the U.S.

● The first company in China to independently self-develop and manufacture bioreactors used for large-scale and industrialized culturing of cells

● The first company in China to acquire the capability of large-scale separation and purification of vaccines and viruses using our proprietary macro porous chromatography resins technology

● The largest laboratory water purification systems provider in China (in terms of revenue in 2021); the first Chinese company entered the U.S. and European laboratory water purification systems markets

● The first company in the world to apply high-pressure homogenizers and nanotechnology on a large scale in the biologics industry

Duoning will stick to its original goal, closely follow the theme of high-quality development, continue to improve the biologics industry chain, and contribute to the realization of a healthy China.